Imagine if this fountain of youth wasn’t actually hidden in some mythical place; rather, it resided in tiny factories abiding in our cells. Though these stuff, known as junk proteins, are not anywhere near to the mythical place called fount of youth, the new revolutionary advances in research show that they play a key role in the whole process of ageing and years-related horrible pathologies, including Amyotrophic Lateral Sclerosis. Of interest is that some cellular processes engaged in the aging process, at play here to understand aging, can very well unlock new treatments for ALS.
What’s happening here? Lets Break it down.
So, our cells are busy cities with molecules of ribosomes working as machines churning out proteins according to the blueprint spelled out in our DNA. It would be right to say that they realize tons of important functions, from building cell structures to catalyzing reactions. At the same time, as with any complicated machine, things can occasionally go wrong, and the result is that cells start to manufacture junk proteins defective proteins that will not work properly but instead will accumulate and cause all kinds of problems.
According to scientists headed by Óscar Fernández-Capetillo of the Spanish National Cancer Research Centre in a recent study, these junk proteins accumulate in high amounts in familial ALS. This kind of ALS is characterized by progressive dying of the motor neurons connected with loss of muscle control, which, finally, ends tragically by decline of bodily functions in people running in families.
Fernández-Capetillo and his team have now found that, under some circumstances, the proteins that form the ribosomes—ribosomal proteins can be “orphaned” and consequently become non-functional. Aggregated, however, they interfere with cellular activity and cause motor neuron death. Something similar occurs in the case of so-called ribosomopathies. These are pathologies that originate from an excess of certain non-functional ribosomal proteins.
One of the more intriguing aspects of the research is that of nucleolar stress. Nucleoli are places in the cell where ribosomes involved in protein synthesis are created. When it’s under stress, they appear in favor of both processes: aging and neurodegenerative diseases. According to the co-author of the study, Vanesa Lafarga, “In our work we report a new model that explains how nucleolar stress induces toxicity in animal cells, and we provide direct evidence that it accelerates aging in mammals.”.
This would not only bring new meaning to ALS but explain the process for large-scale aging if junk proteins are associated with nucleolar stress. It suggests that controlling the production of ribosomes could provide an approval for fighting both ALS and age-related cellular decay.
They found that genetic and pharmacological reductions of ribosomes can reduce the toxic effects of these junk proteins of tissue cultures. Fernández-Capetillo tempered things a bit by stating that they are still at a very preliminary stage: “We are in the first steps to see if we can give a therapeutic angle to these findings.” The potential here, however, is enormous—if scientists could find a way to effectively balance the production of ribosomes, that might just be the key to opening new avenues for treating ALS and even contributing to anti-aging therapies.
Moreover, the implications of this study do not confine themselves to ALS. According to the research, extreme nucleolar stress might contribute enormously to normal aging. Actually, in the animal models that express the ALS-related toxins, the paradigm of severe nucleolar stress was linked not only with motor neuron death but even ushers in accelerated aging. Surprisingly, animals that are treated with a drug that lowers the synthesis of ribosomes in a test of sorts as to whether or not cutting down on junk protein formation might forestall aging live longer.
This puts us at an exciting crossroads in scientific research. The finding that junk proteins and nucleolar stress are hallmarks of both aging and ALS points to completely new avenues for therapeutic strategies. We can intervene in the cellular processes to cure not just ALS but more broadly, and importantly, support healthier aging.
Óscar Fernández-Capetillo, however, considers it to be just a stepping stone to more in-depth research and hence manages his optimism. “Our work opens a new door, a new angle, to explain what can be the molecular origin of pathologies such as ALS, and perhaps also of aging as a whole. Yet, one should not be misled that by doing this we propose any kind of therapy already. There’s so much to do, and we can only perhaps hope that others will also be inspired by our ideas and offer their assistance on the therapeutic implications from our discoveries.”.
It may perhaps only define one landmark in responsibly and profoundly going deep into the currents of understanding processes of aging and neurodegenerative diseases such as ALS. The deeper scientists deliberate on the intricate dance of ribosomes, nucleoli, and junk proteins inside our cells, the closer it brings us to probably life-altering treatments that would have assured better quality of life and longevity for many.
While the fabled fountain of youth may always feature thematically, the real secret to slowing senescence and battling disorders like ALS lies in the tiny, mighty ribosomes of our cells. Indeed, the deeper science researches into the mysteries of cells, the further it takes us toward the unlocking of healthy aging.
